🇺🇸 FDA
Patent

US 9518262

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

granted A61PA61P1/00A61P1/02

Quick answer

US patent 9518262 (Methods and compositions for the specific inhibition of gene expression by double-stranded RNA) held by INTEGRATED DNA TECHNOLOGIES, INC. expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INTEGRATED DNA TECHNOLOGIES, INC.
Grant date
Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
54
CPC classes
A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/16